MIGREN VA FIBROMIALGIYA KOMORBIDLIGIDA VEGETATIV SIMPTOMLARNING KLINIK XUSUSIYATLARI
##article.subject##:
Migren, Fibromialgiya, Vegetativ disfunksiya, komorbidlik, HADS, COMPASS-31, FIQ##article.abstract##
Migren va fibromialgiya — surunkali og‘riq sindromlari bo‘lib, ular ko‘pincha birgalikda uchraydi va bemorlarning hayot sifatini keskin pasaytiradi. Ushbu tadqiqotning maqsadi migren, fibromialgiya va ularning komorbidligida vegetativ simptomlarning klinik xususiyatlarini aniqlash va qiyosiy baholashdan iborat. Tadqiqotga jami 50 nafar bemor jalb qilindi :20 nafar migren, 15 nafar fibromialgiya, 15 nafar komorbid holatdagi bemorlar, nazorat guruhi sifatida esa 20 nafar sog‘lom shaxs tekshirildi. Vegetativ simptomlar COMPASS-31, fibromialgiya og‘irligi FIQ, psixoemotsional holat esa HADS shkalalari yordamida baholandi. Natijalar komorbid guruhda vegetativ simptomlarning chastotasi va og‘irligi sezilarli darajada yuqoriligini ko‘rsatdi. Xulosa qilib, migren va fibromialgiya komorbidligida vegetativ disfunksiya yanada yaqqol namoyon bo‘ladi hamda tashxis va davolash jarayonida alohida yondashuvni talab qiladi.
Библиографические ссылки
GBD 2016 Headache Collaborators. (2018). Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis. The Lancet Neurology, 17(11), 954–976. https://doi.org/10.1016/S1474-4422(18)30322-3
Clauw, D. J. (2014). Fibromyalgia: A clinical review. JAMA, 311(15), 1547–1555. https://doi.org/10.1001/jama.2014.3266
Peres, M. F. P., Young, W. B., Kaup, A. O., Zukerman, E., & Silberstein, S. D. (2002). Fibromyalgia is common in patients with transformed migraine. Neurology, 58(6), 902–905. https://doi.org/10.1212/WNL.58.6.902
Üçeyler, N., Sommer, C., & Walitt, B. (2015). Anticonvulsants in fibromyalgia syndrome: A systematic review and meta-analysis. Arthritis Care & Research, 67(6), 791–800. https://doi.org/10.1002/acr.22523
Dodick, D. W. (2018). A Phase-by-Phase Review of Migraine Pathophysiology. Headache: The Journal of Head and Face Pain, 58(S1), 4–16. https://doi.org/10.1111/head.13300
Martínez-Martínez, L. A., Mora, T., Vargas, A., Fuentes-Iniestra, M., & Martínez-Lavín, M. (2014). Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: A review. Clinical and Developmental Immunology, 2014, 489187. https://doi.org/10.1155/2014/489187
Raj, S. R., Guzman, J. C., Harvey, P., Richer, L., Schondorf, R., & Seifer, C. (2020). Autonomic dysfunction in fibromyalgia syndrome: Postural orthostatic tachycardia syndrome and beyond. Seminars in Arthritis and Rheumatism, 50(5), 1062–1071. https://doi.org/10.1016/j.semarthrit.2020.06.007
Burstein, R., & Jakubowski, M. (2019). The hypothalamus and migraine: Integrating migraine neurobiology. Headache: The Journal of Head and Face Pain, 59(6), 951–965. https://doi.org/10.1111/head.13528
Schulte, L. H., & May, A. (2016). The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Cephalalgia, 36(7), 670–679. https://doi.org/10.1177/0333102415623076
Akerman, S., Holland, P. R., & Goadsby, P. J. (2017). Diencephalic and brainstem mechanisms in migraine. Nature Reviews Neuroscience, 18(10), 573–586. https://doi.org/10.1038/nrn.2017.101
. Holland, P. R., Barloese, M., & Fahrenkrug, J. (2021). PACAP and orexin in migraine pathophysiology. The Journal of Headache and Pain, 22(1), 118. https://doi.org/10.1186/s10194-021-01340-5
Vetvik, K. G., & MacGregor, E. A. (2017). Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. The Lancet Neurology, 16(1), 76–87. https://doi.org/10.1016/S1474-4422(16)30293-9
Alstadhaug, K. B. (2009). Migraine and the hypothalamus. Cephalalgia, 29(8), 809–817. https://doi.org/10.1111/j.1468- 2982.2009.01996.x
Aurora, S. K., & Brin, M. F. (2017). Gastrointestinal manifestations of migraine. Headache, 57(9), 1423–1434. https://doi.org/10.1111/head.13116
Chen, J. R., Zhou, H. L., Chen, J. M., et al. (2018). Delayed gastric emptying in migraineurs. Cephalalgia, 38(3), 535–543. https://doi.org/10.1177/0333102416683910
Van Den Steen, G., Van Oudenhove, L., & Paemeleire, K. (2020). Migraine and the gut: Mechanisms and clinical implications. Current Opinion in Neurology, 33(3), 305–313. https://doi.org/10.1097/WCO.0000000000000827
Aamodt, A. H., Stovner, L. J., Hagen, K., et al. (2018). Comorbidity of headache and gastrointestinal complaints: The HUNT study. Cephalalgia, 28(2), 144–151. https://doi.org/10.1111/j.1468-2982.2007.01479.x
Sommer, C., & Üçeyler, N. (2024). Small fiber pathology in fibromyalgia syndrome. Pain, 165(5), 901–909. https://doi.org/10.1097/j.pain.0000000000003019
Di Bari, A., Demo, G., & Patron, E. (2025). Unravelling the relationship between anxiety, autonomic nervous system dysfunction and fibromyalgia: A systematic review. Clinical and Experimental Rheumatology, 43(1), 45–56. https://doi.org/10.5555/clinexprheum.2025.43.1.45
